The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(4-chloro-3-methoxyphenyl)-2-[[(2-fluoro-6-nitrophenyl)methyl]sulfanyl]-1-(4-fluorophenyl)-4,5,6,7-tetrahydro-1H-1,3-benzodiazole ID: ALA4087370
PubChem CID: 118464639
Max Phase: Preclinical
Molecular Formula: C27H22ClF2N3O3S
Molecular Weight: 542.01
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(C2CCCc3nc(SCc4c(F)cccc4[N+](=O)[O-])n(-c4ccc(F)cc4)c32)ccc1Cl
Standard InChI: InChI=1S/C27H22ClF2N3O3S/c1-36-25-14-16(8-13-21(25)28)19-4-2-6-23-26(19)32(18-11-9-17(29)10-12-18)27(31-23)37-15-20-22(30)5-3-7-24(20)33(34)35/h3,5,7-14,19H,2,4,6,15H2,1H3
Standard InChI Key: KPSJFBOIUGFALY-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
11.9947 -7.6811 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4751 -6.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9854 -6.3466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2061 -6.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2102 -7.4286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4885 -6.1985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7751 -6.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7794 -7.4389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5010 -7.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2546 -8.4645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7055 -9.0803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9696 -9.8638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7745 -10.0275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3236 -9.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0637 -8.6282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0345 -10.8110 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.2861 -6.9956 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.7019 -6.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5280 -6.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9590 -6.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7756 -6.9604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1760 -6.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7505 -5.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9092 -5.5570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5028 -4.8475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6767 -4.8475 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9187 -4.1259 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5438 -7.6925 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.5010 -8.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7917 -9.0914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8028 -9.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5176 -10.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2268 -9.9033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2227 -9.0812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0934 -10.3318 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0934 -11.1579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5176 -11.1478 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
5 9 1 0
4 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
13 16 1 0
1 10 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
25 26 2 0
25 27 1 0
24 25 1 0
20 28 1 0
18 19 1 0
17 18 1 0
2 17 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
29 34 2 0
35 36 1 0
31 35 1 0
32 37 1 0
9 29 1 0
M CHG 2 25 1 27 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 542.01Molecular Weight (Monoisotopic): 541.1038AlogP: 7.48#Rotatable Bonds: 7Polar Surface Area: 70.19Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.35CX LogP: 7.93CX LogD: 7.93Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.14Np Likeness Score: -1.56
References 1. Zhang X, Wall M, Sui Z, Kauffman J, Hou C, Chen C, Du F, Kirchner T, Liang Y, Johnson DL, Murray WV, Demarest K.. (2017) Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes., 8 (5): [PMID:28523111 ] [10.1021/acsmedchemlett.7b00116 ]